Preventing clonal selection is challenging due to the inherent genetic instability of cancer cells. However, early detection and treatment can minimize the chances of clonal selection by removing or killing cancer cells before they accumulate significant mutations. Additionally, combination therapies that target multiple pathways simultaneously may reduce the likelihood of any single clone becoming dominant.
